Author:

N. H. Hewitt, K. F. Urbancic, A. P. Grigg, M. L. Grayson

Date: 25 September 2013

Abstract:

Oral PCZ is effective antifungal prophylaxis in high risk neutropenic patients. However, achieving adequate plasma PCZ levels can be problematic due to variable absorption with the current formulation. The role of AFS and therapeutic drug monitoring (TDM) for PCZ prophylaxis remains controversial.

Link to DOI

Download the full article (Disclaimer)

This manuscript library of ~16,000 articles (1729-2024) related to Aspergillus and aspergillosis is intended for individual study only, and is provided as contribution to global understanding of the topic. Please refer to the publisher’s guidance about any other usage.

I understand (click to accept and view download link)

---